FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for treatment of infected wounds, burns and trophic ulcers. Antimicrobial gel for the treatment of infected wounds, burns and trophic ulcers contains alpha-defensin-1 (HNP-1), PEG 12 dimethicone, gellant, triethanolamine and purified water. In this case HNP-1 is encapsulated in niosomes formed with PEG 12 dimethicone. Components are used in claimed quantity. Gel allows not only to destroy the pathogenic bacteria in the wound, but also to accelerate the healing speed of wounds.
EFFECT: use of organosilicon nanocontainers-niosomes with active substances allows them to be delivered to deep layers of the skin, reduce inflammation, improve microcirculation, and destroy bacteria and fungi.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NIOSOMAL ANTIMICROBIAL GEL FOR TREATING DIABETIC ULCERS, WOUNDS, BURNS, INCLUDING THOSE INFECTED WITH ANTIBIOTIC-RESISTANT MICROORGANISMS | 2021 |
|
RU2781402C2 |
| BACTERICIDAL PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION IN THE FORM OF AN ENDOLYSIN-CONTAINING BACTERICIDAL GEL | 2021 |
|
RU2781050C1 |
| METHOD OF ISOLATING ENDOGENOUS ANTIMICROBIAL PEPTIDES FROM PLACENTAL TISSUE | 2022 |
|
RU2813979C2 |
| METHOD OF OBTAINING NIOSOMAL FORM OF GENTAMICIN | 2023 |
|
RU2805933C1 |
| METHOD OF PHARMACOLOGICAL CORRECTION OF POST-TRAUMATIC DISORDERS OF IMMUNITY AND REPARATIVE PROCESSES IN EXPERIMENT | 2018 |
|
RU2698801C1 |
| DENTAL GEL HAVING NIOSOMES FOR TREATMENT OF INFLAMMATORY AND DYSTROPHIC PERIODONTAL DISEASES | 2013 |
|
RU2582290C2 |
| STABILISED PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES CAUSED BY VENOUS INSUFFICIENCY | 2011 |
|
RU2458694C1 |
| NOVEL SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION | 2010 |
|
RU2571506C2 |
| ENZYMATIC WOUND HEALING MEDICATION | 2011 |
|
RU2484811C2 |
| DOXORUBICIN AND ORGANOSILICON NANOPARTICLES-NIOSOMES- BASED PHARMACEUTICAL GEL FOR SKIN CANCER TREATING | 2014 |
|
RU2600164C2 |
